SUPRAME Phase 3 interim and final analysis for PRAME cell therapy, anzu-cel, expected to be triggered in 2026, advancing toward the Company’s ...
Defense Metals Corp. , a company focused on the development of its wholly-owned Wicheeda Rare Earth Project , located near ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results